Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Phenotypic and Functional Characterization of Multiple Myeloma By Single Cell Mass Cytometry (CyTOF)

Linda B Baughn, PhD, Erik Jessen, PhD, Matthew Smith, Neeraj Sharma, PhD, Joselle Cook, MBBS, Surendra Dasari, PhD, Kathryn E. Pearce, MS, Nathalie Meurice, PhD, Michael A. Linden, MDPhD, A. Keith Stewart, MB, ChB, P. Leif Bergsagel, MD, Brian G. Van Ness, PhD, Shaji K. Kumar, MD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-141639

Published: 2020

Journal Articles

Profiling the Cell Surface Landscape of Proteasome Inhibitor-Treated and -Resistant Multiple Myeloma to Guide Immunotherapy Targeting, Diagnosis, and Biology

Ian Ferguson, BA, Yu-Hsiu T. Lin, BA, Sami Tuomivaara, PhD, Jeffrey L. Wolf, MD, Thomas G. Martin, III, MD, Sandy W. Wong, MD, Nina D. Shah, MD, Christoph Driessen, MD, Brian G. Van Ness, PhD, Arun P. Wiita, MD PhD

Blood (2019) 134 (Supplement_1): 1803.

https://doi.org/10.1182/blood-2019-131681

Published: 2019

Journal Articles

Repurposing Clofazimine As a Novel Drug for the Treatment of PI-Resistant Stem Cell-like Subclones in Myeloma

Harish Kumar, PhD, Ujjal Kumar Mukherjee, PhD, Suman Mazumder, PhD, Sabyasachi Sanyal, PhD, Brian G. Van Ness, PhD, Amit Kumar Mitra, PhD MSc, BSc

Blood (2019) 134 (Supplement_1): 4418.

https://doi.org/10.1182/blood-2019-131596

Published: 2019

Journal Articles

Secdrug: A Computational Method for Discovering Novel Secondary Drug Combinations Using Large-Scale Pharmacogenomics Databases

Li Chen, PhD, Ujjal Kumar Mukherjee, PhD, Emily Rankine, Brian G. Van Ness, PhD, Amit Kumar Mitra, PhD

Blood (2018) 132 (Supplement 1): 4473.

https://doi.org/10.1182/blood-2018-99-117653

Published: 2018

Journal Articles

Gene Expression Profiling of Kinetic Response to Proteasome Inhibitors in Innate and Acquired Resistant Multiple Myeloma

Amit Kumar Mitra, PhD, Vijay G. Ramakrishnan, PhD, Shaji K Kumar, MD, S. Vincent Rajkumar, MD, Brian G. Van Ness, PhD

Blood (2017) 130 (Supplement 1): 4405.

https://doi.org/10.1182/blood.V130.Suppl_1.4405.4405

Published: 2017

Journal Articles

Scattome: A Single-Cell Analysis of Targeted Transcriptome Program to Predict Drug Sensitivity of Single Cells within Human Myeloma Tumors

Amit Kumar Mitra, PhD, Ujjal Mukherjee, PhD, Taylor Harding, Holly Stessman, PhD, Ying Li, Jen Jin, Shaji K Kumar, MD, S. Vincent Rajkumar, Brian G Van Ness, PhD

Blood (2015) 126 (23): 4249.

https://doi.org/10.1182/blood.V126.23.4249.4249

Published: 2015

Journal Articles

Creation of a Gene Expression Signature-Based Prediction Model Specific to Proteasome Inhibitor Response in Multiple Myeloma

Amit Kumar Mitra, PhD, Ujjal Mukherjee, PhD, Taylor Harding, Snigdhansu Chatterjee, PhD, Brian G Van Ness, PhD

Blood (2015) 126 (23): 3053.

https://doi.org/10.1182/blood.V126.23.3053.3053

Published: 2015

Journal Articles

Genetic Variations Associated with Overall and Progression-Free Survival in Multiple Myeloma Patients Treated with Thalidomide Combinations.

David C Johnson, BSc, Walter M Gregory, PhD, Nicholas J Dickens, DPhil, Brian A Walker, PhD, Alex J Szubert, MSc, Faith E Davies, MD, Brian G M Durie, MD, Brian G Van Ness, PhD, Gareth J Morgan, MD, PhD

Blood (2009) 114 (22): 426.

https://doi.org/10.1182/blood.V114.22.426.426

Published: 2009

Journal Articles

Genetic Variation in ADME Genes Is Associated with Thalidomide Related Peripheral Neuropathy in Multiple Myeloma Patients.

David C Johnson, Christine Ramos, Alex J. Szubert, Walter M Gregory, J. Anthony Child, Faith E Davies, MD, Brian GM Durie, MD, Brian G. Van Ness, PhD, Gareth J Morgan, MD, PhD

Blood (2008) 112 (11): 1675.

https://doi.org/10.1182/blood.V112.11.1675.1675

Published: 2008

Journal Articles

Large Scale Evaluation of Genetic Variation and the Risk of Multiple Myeloma.

Sonja I Berndt, David C Johnson, John Crowley, Brian G Durie, MD, Robert Hoover, Michael Katz, Nathaniel Rothman, Brian G. Van Ness, PhD, Dalsu Baris, MD, PhD, Gareth J Morgan, MD, PhD

Blood (2008) 112 (11): 1679.

https://doi.org/10.1182/blood.V112.11.1679.1679

Published: 2008

Journal Articles

Transgenic Mouse Modeling of Therapeutic Responses in Myeloma

Brian G. Van Ness, PhD, Christine Ramos, Mary Gosse

Blood (2008) 112 (11): 2747.

https://doi.org/10.1182/blood.V112.11.2747.2747

Published: 2008

Journal Articles

Analytical Approaches for the BOAC SNP Panel Association with Progression Free Survival in Myeloma

Brian G. Van Ness, PhD, Christine Ramos, Vipin Kumar, Michael Steinbach, Brian GM Durie, MD, John Crowley, PhD, Bart Barlogie, Antje Hoering, Jeff Haessler, David C Johnson, Gareth J Morgan, MD, PhD

Blood (2008) 112 (11): 2715.

https://doi.org/10.1182/blood.V112.11.2715.2715

Published: 2008

Journal Articles

SNP Associations with Event Free Survival in Myeloma from Two Phase III Clinical Trials Using the Bank On A Cure Chip.

Brian G. Van Ness, PhD, John C. Crowley, Ph.D., Christine Ramos, B.S., Suzanne M. Grindle, Ph.D., Antje Hoering, Ph.D., Jeff Haessler, M.S., Susanna Jacobus, M.S., Brian G. Durie, MD, Michael Katz, Ph.D., Vincent S. Rajkumar, MD, Bart Barlogie, MD, David C. Johnson, Ph.D., Gareth J. Morgan, MD

Blood (2006) 108 (11): 131.

https://doi.org/10.1182/blood.V108.11.131.131

Published: 2006

Journal Articles

The Genetic Contribution to the Aetiology of Thalidomide Associated VTE.

Gareth J. Morgan, MD, PhD, David C. Johnson, BSc, John Crowley, PhD, John Shaughnessy, Jr., PhD, Pieter Sonneveld, MD, Brian Durie, MD, Christine Ramos, PhD, Brian G. Van Ness, PhD, Bart Barlogie, MD, Antje Hoering, PhD, Jeff Haessler, PhD, Dalsu Baris, MD, PhD, Michael Katz, BS, Vincent S. Rajkumar, MD, H. Goldschmidt, MD

Blood (2006) 108 (11): 246.

https://doi.org/10.1182/blood.V108.11.246.246

Published: 2006

Journal Articles

Inherited Genetic Variation and the Risk of Developing Venous Thrombosis with Thalidomide Treatment in Myeloma Patients.

David C. Johnson, BSc, Suzanne Grindle, BS, Faith Davies, MD, David Gonzalez, PhD, Christine Ramos, PhD, Kim Hawkins, MSc, Suzanne Bell, PhD, Heather Kesby, BSc, S. Vincent Rajkumar, MD, Erik Rassmusen, PhD, John Crowley, PhD, Emily Blood, PhD, J. Anthony Child, MD, Brian G.M. Durie, MD, Brian G. Van Ness, PhD, Gareth J. Morgan, MDPhD

Blood (2005) 106 (11): 1624.

https://doi.org/10.1182/blood.V106.11.1624.1624

Published: 2005

Journal Articles

A Trangenic Mouse Model of Plasma Cell Malignancy Shows Cytogenetic and Gene Expression Profiles Similar to Human Multiple Myeloma.

Kristin Boylan, PhD, Mary A. Kvitrud, BA, Brian G. Van Ness, PhD

Blood (2005) 106 (11): 619.

https://doi.org/10.1182/blood.V106.11.619.619

Published: 2005

Journal Articles

Development of a Panel of 3,500 SNP Based Functional Genetic Variants Relevant to the Etiology and Outcome in Multiple Myeloma.

David C. Johnson, BSc, Suzanne M. Grindle, BS, Christine Ramos, PhD, Faith Davies, MD, David Gonzalez, PhD, Brian A. Walker, PhD, Brian G.M. Durie, MD, Brian G. Van Ness, Phd, Gareth J. Morgan, MD, PhD

Blood (2005) 106 (11): 620.

https://doi.org/10.1182/blood.V106.11.620.620

Published: 2005

Journal Articles

Targeted Overexpression of Mutant Activated N- ras Leads to Aberrant Plasma Cell Biology.

Michael A. Linden, PhD, Nicole Kirchhof, DVM, Brian G. Van Ness, PhD

Blood (2004) 104 (11): 1416.

https://doi.org/10.1182/blood.V104.11.1416.1416

Published: 2004

NARROW

Phenotypic and Functional Characterization of Multiple Myeloma By Single Cell Mass Cytometry (CyTOF)

Profiling the Cell Surface Landscape of Proteasome Inhibitor-Treated and -Resistant Multiple Myeloma to Guide Immunotherapy Targeting, Diagnosis, and Biology

Repurposing Clofazimine As a Novel Drug for the Treatment of PI-Resistant Stem Cell-like Subclones in Myeloma

Secdrug: A Computational Method for Discovering Novel Secondary Drug Combinations Using Large-Scale Pharmacogenomics Databases

Gene Expression Profiling of Kinetic Response to Proteasome Inhibitors in Innate and Acquired Resistant Multiple Myeloma

Scattome: A Single-Cell Analysis of Targeted Transcriptome Program to Predict Drug Sensitivity of Single Cells within Human Myeloma Tumors

Creation of a Gene Expression Signature-Based Prediction Model Specific to Proteasome Inhibitor Response in Multiple Myeloma

Genetic Variations Associated with Overall and Progression-Free Survival in Multiple Myeloma Patients Treated with Thalidomide Combinations.

Genetic Variation in ADME Genes Is Associated with Thalidomide Related Peripheral Neuropathy in Multiple Myeloma Patients.

Large Scale Evaluation of Genetic Variation and the Risk of Multiple Myeloma.

Transgenic Mouse Modeling of Therapeutic Responses in Myeloma

Analytical Approaches for the BOAC SNP Panel Association with Progression Free Survival in Myeloma

SNP Associations with Event Free Survival in Myeloma from Two Phase III Clinical Trials Using the Bank On A Cure Chip.

The Genetic Contribution to the Aetiology of Thalidomide Associated VTE.

Inherited Genetic Variation and the Risk of Developing Venous Thrombosis with Thalidomide Treatment in Myeloma Patients.

A Trangenic Mouse Model of Plasma Cell Malignancy Shows Cytogenetic and Gene Expression Profiles Similar to Human Multiple Myeloma.

Development of a Panel of 3,500 SNP Based Functional Genetic Variants Relevant to the Etiology and Outcome in Multiple Myeloma.

Targeted Overexpression of Mutant Activated N- ras Leads to Aberrant Plasma Cell Biology.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only